Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Or... (rietaryor partner product candidates may...)

Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization

Date:2/12/2008

rietary or partner product candidates may not issue, patents that have issued may be unenforceable, or intellectual property licenses from third parties may be required in the future, and (vi) the company may be unable to secure a new partner for its inhaled insulin programs (Exubera(R) and its inhaled insulin development program) on commercially favorable terms or at all. Other important risks and uncertainties are detailed in the company's reports and other filings with the SEC; including its most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K.

Contacts:

Tim Warner (650) 283-4915 or twarner@nektar.com

Stephan Herrera (415) 488-7699 or sherrera@nektar.com

Jennifer Ruddock (650) 631-4954 or jruddock@nektar.com

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
2. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
3. Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
4. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
5. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
6. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
7. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
8. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
9. PAREXEL International Announces 2-For-1 Stock Split
10. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
11. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital

Post Your Comments:

(Date:6/19/2013)... June 19, 2013 Applied Rigaku Technologies, ... that details the measurement of sulfur in ultra-low sulfur ... high resolution benchtop EDXRF analyzer . The analysis detailed ... method ISO 13032. This International Standard specifies an ... determination of sulfur content in automotive gasoline. , Regulations ...

(Date:6/19/2013)... San Diego, CA (PRWEB) June 19, 2013 ... quality pipettes, Pipette.com is now stocked with Simport’s Dropette® ... , all aimed at the customer doing basic biology, ... blood work, and serology). , For over 35 years, ... and disposable plastic labware - products like the Simport ...

(Date:6/18/2013)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing, and ... financial results for the fourth quarter and full year ... Fourth Quarter of Fiscal 2013 Highlights ... increased by 33.3% to RMB133.0 million ($21.4 million) from ...

(Date:6/18/2013)... 18, 2013 The Regulatory Affairs ... two new offices in Asia—one in Singapore and one ... as RAPS’ Pan-Asia office , serving the Asia ... focused on audiences within China. , The announcement comes ... with five Singapore government agencies to develop and implement ...

[0] Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 [0] Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] RAPS Opens Offices in Singapore and China

... A Night of Music & Comedy to Help Push Campaign to Victory May 14, 2008 ... Highline Ballroom, Spring ... ... Policy Project (MPP.org),will host a spring soiree, a night of comedy and music to benefit ...

... 13 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products Group Corporation ... agreement establishing a joint venture company,capable of ... May 9, General Manager of Shijiazhuang Huaxing ... and his associates visited Kiwa,s,headquarters in Beijing ...

... May 13 , - Regulated Information, ... on innovative treatments for vascular disease, eye disease ... the three month period ended,31 March 2008., ... commenting on,today,s announcement, said: "ThromboGenics, clinical development programs,are ...

Cached Biology Technology:New York Benefit to Celebrate Recent Medical Marijuana Successes 2 Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd. 2 Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd. 3 ThromboGenics N.V. - Business Update 2 ThromboGenics N.V. - Business Update 3 ThromboGenics N.V. - Business Update 4 ThromboGenics N.V. - Business Update 5 ThromboGenics N.V. - Business Update 6 ThromboGenics N.V. - Business Update 7

New York Benefit to Celebrate Recent Medical Marijuana Successes Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd.ThromboGenics N.V. - Business Update

(Date:6/18/2013)... not a hacker lab. At Brandeis University, sophisticated ... are helping scientists understand the complex interplay between ... the virus, outer "shell" critical for replication. ... what we are finding will help researchers alter ... post-doctoral fellow Jason Perlmutter, first author of the ...

(Date:6/18/2013)... Joshua Obar, Ph.D., Department of Immunology and Infectious ... 2013 ICAAC Young Investigator Award for his research on ... to infection. , Obar earned his B.A. in ... on to complete his Ph.D. in Microbiology and Immunology ... Ph.D. thesis research in Edward Usherwood,s laboratory at the ...

(Date:6/18/2013)... DNA and this modification can occur in millions ... scientists believed that this epigenetic phenomenon actively reduced ... of researchers from the University of Geneva (UNIGE), ... the Faculty of Medicine, reveals that this is ... may play both a passive and active role ...

Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2 The American Society for Microbiology honors Joshua Obar 2 The secret of DNA methylation 2

[0] Computer modeling technique goes viral at Brandeis [0] The American Society for Microbiology honors Joshua Obar [0] The secret of DNA methylation

... being slowly stroked on the skin have their own specialised ... new study from the Sahlgrenska Academy, University of Gothenburg, Sweden. ... pain. The specialised nerve fibres in the skin are called ... in the brain that are important in the emergence of ...

... 13, 2009 -- Investigators at the Burnham Institute for ... differentiate human embryonic stem cells (hESCs) into neural progenitor ... conducted by Alexei Terskikh, Ph.D., and colleagues, outlines a ... that is replicable, does not produce mutations in the ...

... Here is the latest American Chemical Society (ACS) Weekly ... news from ACS, 34 peer-reviewed journals and Chemical & ... Chemical Society as the source for this information. ... ARTICLE # 1 FOR IMMEDIATE RELEASE, Solving the ...

Signals from stroking have direct route to brain Creating ideal neural cells for clinical use American Chemical Society Weekly PressPac -- April 8, 2009

... tabs • Reusable, press-to-seal gasket and ... assembled and disassembled for hybridizing and imaging ... thickness with up to a 13 mm ... slide. Minimize specimen handling, eliminate evaporation and ...

...

... A direct, simple approach to ... well surface of an EIA ... maintains its integrity and availability ... dry, room temperature conditions ...

AC input: 230 V...

Biology Products:

Modular hybridization system from Sigma-Aldrich LC-NMR-MSn system from Bruker Daltonics Reacti-Bind Maleic Anhydride Activated Polystyrene 96-Well plates from Pierce Biotechnology, Inc.Slide Moat Microscope Slide Incubator from Sigma-Aldrich